Navigation Links
Abbott and Pierre Fabre SA Announce Collaboration to Research and Develop Novel Treatments for Cancer
Date:2/1/2010

ABBOTT PARK, Ill. and CASTRES, France, Feb. 1 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) announced today an exclusive worldwide licensing agreement with Pierre Fabre SA to develop and commercialize h224G11, a pre-clinical monoclonal antibody identified at the Centre d'Immunologie Pierre Fabre (CIPF) in France and targeting the cMet receptor for the treatment of cancer.  cMet protein plays a role in the progression of a range of solid tumors including, prostate, lung and gastric cancers and mediates resistance to chemotherapy.  As part of the agreement, the companies also intend to collaborate on research to explore next-generation cMet antibodies.  

"cMet is a compelling cancer target and the early research on this compound looks promising," John Leonard, M.D., senior vice president, global research and development, Abbott. "We look forward to adding to our strong oncology pipeline, which includes exploration of multiple mechanisms to treat cancer."

H224G11 works by specifically binding to cMet protein and interrupting the signaling pathway, which leads to cancer cell death and the prevention of tumor growth. The antibody also inhibits cancer cell migration and angiogenesis.  

"Using the strengths of its dedicated research team in biotechnology, Pierre Fabre SA has been able to develop potent and protein specific inhibitors of the cMet receptor. We are delighted to partner this important asset with Abbott scientists," declared Jean-Pierre Garnier, Chief Executive Officer of Pierre Fabre SA.

Under the terms of the collaboration and license agreement, Abbott will lead the development and commercialization of mo
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Abbotts Ibis Technology Named One of the Top Innovations for 2009 by The Scientist
2. The Deal Names Abbott Top Dealmaker for Second Consecutive Year
3. Abbott Completes Visiogen Acquisition
4. Abbott Cuts Use of Oil and Coal by 35 Percent
5. Results from Abbotts PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease
6. Abbotts XIENCE V(R) Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS(R) Liberte in Investigator-Initiated COMPARE Trial
7. Abbotts XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial
8. Abbotts XIENCE V(R) Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long-Term Safety Results in SPIRIT III Trial
9. HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials
10. New Data for Abbotts TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management
11. Abbotts Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... CARLSBAD, Calif. , July 10, 2014 /PRNewswire/ ... products and services, has launched the FreeRunner™ knee ... runners, who suffer from patella mal-tracking return to ... anatomy differently than other braces, providing support when ... move normally when they don,t. Patellofemoral ...
(Date:7/10/2014)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... sale to Galderma of all rights to Restylane, Perlane, ... for $1.4 billion in cash, pursuant to the previously ... acquisition of Galderma. "We are pleased ... company that is firmly committed to the aesthetic dermatology ...
(Date:7/10/2014)... -- Decision Resources Group finds that over half of ... Drug Administration,s (FDA) approval of Vifor Fresenius Medical Care ... by the FDA in November 2013 for the treatment ... dialysis. Other key findings from the report ... : , Bundling: Based ...
Breaking Medicine Technology:Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3
... 2011 Researchers presented data demonstrating increased specificity ...  MRI for the detection of breast cancer at ... National Interdisciplinary Breast Center Conference held March 12 ... poster presentation, titled Pre-Surgical Detection of Malignancies ...
... Varian Medical Systems (NYSE: VAR ) announced ... fiscal year 2011 following the close of regular trading on ... by a teleconference available to all interested parties at 2:00 ... conference call webcast will be available on the company website ...
Cached Medicine Technology:Researchers Present Key Findings Comparing PEM to MRI for Identification of Contralateral Breast Cancer at the National Consortium of Breast Centers (NCBC) Conference 2Varian Medical Systems Schedules Second Quarter FY2011 News Release and Conference Call 2
(Date:7/11/2014)... 11, 2014 Netmail, ... with its unique Netmail Platform, today announced that ... Conference (WPC), which will be held in Washington’s ... 2014. During the show, Netmail will officially launch ... solution that consolidates email security, archiving, encryption, eDiscovery, ...
(Date:7/11/2014)... July 11, 2014 Based in Pearland, ... to residents of Brazoria County and surrounding counties. Recently, ... clinic is now accessible from Northbound Highway 288 and ... center where patients can get low-cost urgent care of ... from rare, finding places that can match the quality ...
(Date:7/10/2014)... July 11, 2014 The Capital Institute ... performed the first procedure in a clinical trial that ... in the leg. , During the procedure, done at ... an endovascular neurosurgeon, threaded a tiny catheter through the ... body and neck and into the brain. Once the ...
(Date:7/10/2014)... 2014 More than 200 experts on ... urban street violence, will attend the 21st World Meeting ... (ISRA) at the Loews Atlanta Hotel, July 15-19. ... prestigious world meeting, which is held every other year ... bringing together leading scholars from more than 20 different ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 Ticketability.com has a ... and now Paul McCartney tickets for San Diego are being ... San Diego since 1976, and the newly added September 28 ... fans. , Click Here to view the selection ... for Petco Park will become available to the general public ...
Breaking Medicine News(10 mins):Health News:Netmail Heads to Washington, D.C. to Demonstrate New Release of Netmail 5.3 at WPC 2014 July 13-17, 2014 2Health News:Netmail Heads to Washington, D.C. to Demonstrate New Release of Netmail 5.3 at WPC 2014 July 13-17, 2014 3Health News:Prime Urgent Care Announces New Access to the Clinic, Available from Northbound Highway 288 2Health News:New Trial Delivers Chemotherapy to Brain Tumor Through Artery in Leg 2Health News:New Trial Delivers Chemotherapy to Brain Tumor Through Artery in Leg 3Health News:Georgia State Hosts National Conference On Aggression 2Health News:Georgia State Hosts National Conference On Aggression 3Health News:Georgia State Hosts National Conference On Aggression 4Health News:Paul McCartney Tickets for San Diego: Ticketability.com Announces Discounted Tickets for McCartney’s Tour Stop at Petco Park on September 28 2
... the Vrije University in Amsterdam in collaboration with the University of ... , Usually in case of throat cancer the larynx or ... removed. , The patients after this surgery find it ... valve is implanted in-between the windpipe and oesophagus. ,But ...
... If smoking were to be banned by the Government ... home will be affected by passive smoking. Children suffer ... passive smoking. The economists belonging to the University College ... anti-smoking campaigners. ,Smokers will be encouraged ...
... Center for Health Studies of Seattle has revealed that chronic ... as 101 adults who suffer from back pain were assessed ... minutes every week displayed greater progress when compared to those ... ,Yoga has also been found to be more useful than ...
... Angeles County health officials which will facilitate the sending of ... diseases. The site called, inSPOTLA.org is meant // to check ... site is targeted at people seeking casual sex on line. ... in 2004 has resulted in as many as 20,000 e-mails. ...
... A new report has revealed that wild thrashing during ... of Parkinson's disease. Professor Claudia Trenkwalder said that disruptions ... could be a signal to approaching Parkinson's disease, according ... muscles are normally relaxed and disconnected from motor controls ...
... The cervical cancer vaccine, Cervarix, appears to work best in ... GlaxoSmithKline (GSK). ,The vaccine targets the human papilloma virus, ... it works pretty well in the 15-25 age group as ... high as that found in this group. This appears to ...
Cached Medicine News:
... a completely automated instrument that offers Rapid ... 6 hour same day turnaround), random or ... It is used for bacterial and yeast ... and has a complete data management system. ...
IDS Rapid One, a microbial identification system....
The Cogent Microbial Luminescence System (MLS) is a superior Rapid microbial detection system for UHT product screening combining proven technology of ATP-bioluminescence with unsurpassed hardware in...
... SkanWasher 300 is an ... designed to give reliable, ... cross-contamination between wells, and ... to plate. The washer ...
Medicine Products: